[Host-graft interactions after allogenic bone marrow transplantation; choice of donor]. 1988

N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
Unité Fonctionnelle de Greffe de Moelle Osseuse, Hôpital Saint-Louis, France.

The complexity of host-graft interactions after bone marrow transplantation explains the criteria of choice of the donor. Graft rejection, graft-versus-host disease, graft-versus-leukemia, delayed immune reconstitution, often associated or mutually exclusive are observed even with an HLA identical sibling donor. Syngeneic transplants may be complicated by leukemic relapse related to the loss of the graft-versus-leukemia effect. The compilation of files of unrelated donors increases the possibility of finding a matched unrelated donor. Preliminary results suggest that clinical results may be equivalent to those achieved with HLA identical sibling donors. Overall results of HLA mismatched transplants are disappointing because of the increase of immunological complications. Attempts at preventing graft-versus-host disease with T cell depletion led to an increase of immunological complications: rejection and leukemic relapse. Modifications of the conditioning regimen and use of in vivo monoclonal antibodies are currently being investigated. Ethical, legal, and psychological considerations have also to be taken into account in the donor choice especially with the increase of the donor pool.

UI MeSH Term Description Entries
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006087 Graft vs Host Reaction An immunological attack mounted by a graft against the host because of HISTOINCOMPATIBILITY when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. HLA Sensitization,Human Leukocyte Antigen Sensitization,Sensitization, HLA
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
June 1991, Zeitschrift fur Gastroenterologie,
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
January 1991, European journal of ophthalmology,
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
January 2003, Italian heart journal : official journal of the Italian Federation of Cardiology,
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
June 2002, American journal of ophthalmology,
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
February 2013, Hepatology (Baltimore, Md.),
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
June 2002, Archives of dermatology,
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
March 2003, Journal of immunology (Baltimore, Md. : 1950),
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
April 1996, Blood,
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
September 2015, Australian dental journal,
N Alby, and A Bernard, and A Devergie, and J M Goldman, and P Hervé, and P Maraninchi, and C Raffoux, and E Gluckman
January 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!